By MATTHEW FOX, Business Insider
With the surging popularity of GLP-1 weight-loss drugs, millions of Americans are poised to collectively shed hundreds of millions of pounds over the next decade — and reshuffle trillions of dollars in the process.
In other words, the stock market is getting Ozempic’ed.